alveoflow Neo · India's first portable oscillometry

Breathe normally.
That's the test.

India's first portable oscillometry device, designed and built in India. Airway resistance and reactance, measured while the patient breathes quietly.

alveoflow Neo, front three-quarter view
Designed, engineered & made in India
  • India's first portable oscillometry
  • Patent pending
  • Design applied for
Powered by alveoSenseAI™Breath-by-breath quality checks, reference or Salvi 2023 cut-offs, small-airway markers

Designed to be held

Light in the hand. Ready in seconds.

One device, one mouthpiece, no cart.

Tidal breathing

15–30 seconds of quiet breathing.

No forced blow. No coaching.1

Results on the device

Six numbers, right on screen.

R5, R19, X5, AX and Fres against predicted.

Quality built in

Accepted. Compared to predicted.

Checks for leaks, swallows and coherence before a result is kept.

Test the patients spirometry can't.

Spirometry needs a maximal, coached blow. Oscillometry measures during the breathing the patient is already doing.

Forced spirometry

  • Maximal breath in, then a hard, fast, sustained blow
  • Coaching, repeat attempts, acceptability criteria
  • Hard for young children, older adults and anyone breathless at rest

alveoflow Neo

  • Quiet breathing through the mouthpiece
  • No coaching, no maximal effort, no learned technique
  • Separates resistance at low and high frequency

Oscillometry complements spirometry. Run Neo and alveoAir Ultra in the same visit when both are needed.

Six numbers.
The whole airway tree.

The device coaches the test.

A 3.5-inch screen guides the operator from first breath to accepted result.

Neo screen: breathe normally, three steady breaths
SettleWaits for three steady breaths and checks for leaks.
Neo screen: keep breathing quietly, live flow and pressure
CaptureLive flow and pressure, with R5 and X5 updating.
Neo screen: recording accepted with results against predicted
AcceptQuality checks, then results against predicted.4

Take a closer look.

alveoflow Neo in profile
Balanced gripScreen, mouthpiece and handle in one line, so the operator can watch the test while the patient breathes.
alveoflow Neo from behind, showing the mouthpiece port
Mouthpiece portSingle-use mouthpiece and filter for every patient.
alveoflow Neo screen showing an accepted recording
Accepted, on the spotQuality checks run before a result is kept.

Measured to the ERS standard.

5–40 Hz
Oscillation frequency range
±3%
Resistance repeatability
<2%
Deviation against reference loads
400 Hz
24-bit acquisition
3.5″
Colour screen

Every result, straight to the Hub.

Neo sends each recording wirelessly to alveo Hub, where it joins the patient's spirometry in one record.

alveoflow Neo with alveo Hub and alveoAir Ultra

Better with alveo Hub

Every Neo test, in the patient's record.

Each recording lands on the Hub next to the patient's spirometry and walk test. Works offline, and syncs to alveoConnect when you are online.

Tech specs

Method
Forced oscillation technique (respiratory oscillometry)
Excitation
Hybrid pseudo-random and chirp waveform
Frequency range
5–40 Hz
Parameters
R5, R20, R5–R20, X5, AX, Fres, intra-breath loops
Test
15–30 s tidal breathing1
Repeatability
±3% resistance, ±5% reactance
Calibration
Automated pre-test, verification against reference load
Display
3.5-inch colour screen
Connectivity
Wireless to alveo Hub
Size
About 112 × 217 × 228 mm
Consumables
Mouthpiece and bacterial/viral filter
Standards
ERS technical standard on respiratory oscillometry (King et al., 2020). IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11. ISO 10993. RoHS.
Regulatory
CDSCO Class B, MDR 2017. ISO 13485, MDSAP. FCC.3

See Neo in your clinic.

  1. Acquisition time of 15–30 seconds of tidal breathing per recording, from the alveoflow FOT System specification. Applies to alveoflow Pro and alveoflow Neo.
  2. FHIR R4 and HL7 v2 export from the alveoflow FOT System specification. ABDM integration supported.
  3. CDSCO Class B under MDR 2017. ISO 13485 and MDSAP as stated on alveo.fit. alveoflow: US 510(k) submission pending; not cleared for sale in the United States. alveoair is US FDA 510(k) cleared (K222525, August 2023).
  4. Screens show example data and do not represent a real patient. Interpretation is the responsibility of the treating clinician.